Modified autologous leukocyte cell therapy

· M2RLAB SL

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Modified autologous leukocyte cell therapy, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery [Phase 2]